DK0673418T3 - Monoklonale antistoffer rettet mod mikrotubulusassocieret tau-protein, hybridomaer, der secernerer disse antistoffer, antig - Google Patents

Monoklonale antistoffer rettet mod mikrotubulusassocieret tau-protein, hybridomaer, der secernerer disse antistoffer, antig

Info

Publication number
DK0673418T3
DK0673418T3 DK94903752T DK94903752T DK0673418T3 DK 0673418 T3 DK0673418 T3 DK 0673418T3 DK 94903752 T DK94903752 T DK 94903752T DK 94903752 T DK94903752 T DK 94903752T DK 0673418 T3 DK0673418 T3 DK 0673418T3
Authority
DK
Denmark
Prior art keywords
tau protein
pct
antigen
monoclonal antibodies
directed against
Prior art date
Application number
DK94903752T
Other languages
English (en)
Inventor
Marc Mercken
De Voorde Andre Van
Marc Vandermeeren
Eugeen Vanmechelen
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Application granted granted Critical
Publication of DK0673418T3 publication Critical patent/DK0673418T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK94903752T 1992-12-14 1993-12-10 Monoklonale antistoffer rettet mod mikrotubulusassocieret tau-protein, hybridomaer, der secernerer disse antistoffer, antig DK0673418T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92403403 1992-12-14
PCT/EP1993/003499 WO1994013795A1 (en) 1992-12-14 1993-12-10 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications

Publications (1)

Publication Number Publication Date
DK0673418T3 true DK0673418T3 (da) 1999-03-01

Family

ID=8211736

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94903752T DK0673418T3 (da) 1992-12-14 1993-12-10 Monoklonale antistoffer rettet mod mikrotubulusassocieret tau-protein, hybridomaer, der secernerer disse antistoffer, antig

Country Status (9)

Country Link
US (1) US5843779A (da)
EP (1) EP0673418B1 (da)
JP (1) JP2879975B2 (da)
AT (1) ATE165866T1 (da)
AU (1) AU690092B2 (da)
DE (1) DE69318420T2 (da)
DK (1) DK0673418T3 (da)
ES (1) ES2118373T3 (da)
WO (1) WO1994013795A1 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811310A (en) * 1986-09-30 1998-09-22 Albert Einstein College Of Medicine Of Yeshiva Univ. The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease
WO1993008302A1 (en) * 1991-10-25 1993-04-29 Itt Automotive Europe Gmbh Monoclonal antibodies directed against the microtubule-associated protein tau
US6121003A (en) * 1994-07-29 2000-09-19 Innogentics N.V. Monoclonal antibodies specific for an epitope of phosphorylated tau, and their use
US6797478B1 (en) * 1998-03-05 2004-09-28 University Of Cincinnati Method of detecting axonal damage, from associated disease states using tau monoclonal antibodies
JP4624559B2 (ja) * 1998-09-08 2011-02-02 イノジェネティックス・ナムローゼ・フェンノートシャップ 初期ｃｎｓダメージのマーカーとしてのタウ
EP1169646A2 (en) * 1999-01-25 2002-01-09 Minerva Biotechnologies Corporation Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
EP1216417A1 (de) * 1999-09-28 2002-06-26 Evotec OAI AG Quantitative analyse und typisierung subzellulärer partikel
CA2397991C (en) 2000-01-24 2017-10-24 Innogenetics N.V. Diagnosis of tauopathies
US20030162230A1 (en) * 2000-09-27 2003-08-28 Reagan Kevin J. Method for quantifying phosphokinase activity on proteins
WO2004081534A2 (en) * 2003-03-12 2004-09-23 Assay Designs, Inc. Phosphokinase assay
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
US7238788B2 (en) * 2004-02-18 2007-07-03 University Of Iowa Foundation Antibodies to phosphorylated tau, methods of making and methods of use
US20070178447A1 (en) * 2006-01-31 2007-08-02 Bethyl Laboratories, Inc. Method for decreasing interference in results of immunochemical methods
HUE055739T2 (hu) * 2009-03-18 2021-12-28 Ac Immune Sa Eljárás terápiás alkalmazásra
UA107571C2 (xx) * 2009-04-03 2015-01-26 Фармацевтична композиція
CA2813493C (en) 2010-10-11 2019-07-09 University Of Zurich Human anti-tau antibodies
GB201111361D0 (en) 2011-07-04 2011-08-17 Nordic Bioscience As Biochemical markers for neurodegenerative conditions
CN104520322B (zh) 2012-04-05 2019-11-15 Ac免疫有限公司 人源化tau抗体
MY176838A (en) 2012-08-16 2020-08-24 Ipierian Inc Methods of treating a tauopathy
US9200068B2 (en) 2012-12-18 2015-12-01 Regents Of The University Of Minnesota Compositions and methods related to tauopathy
LT2935326T (lt) 2012-12-21 2020-12-10 Biogen Ma Inc. Žmogaus antikūnai prieš tau baltymą
US8980270B2 (en) 2013-01-18 2015-03-17 Ipierian, Inc. Methods of treating a tauopathy
CU24446B1 (es) 2013-03-13 2019-10-04 Prothena Biosciences Ltd Un anticuerpo monoclonal humanizado que se une a tau
KR102233349B1 (ko) 2013-03-15 2021-03-31 에이씨 이뮨 에스.에이. 항-타우(tau) 항체 및 사용 방법
NZ630610A (en) 2014-02-14 2019-05-31 Ipierian Inc Tau peptides, anti-tau antibodies, and methods of use thereof
EP3452508A1 (en) 2016-05-02 2019-03-13 Prothena Biosciences Limited Antibodies recognizing tau
JP7170316B2 (ja) 2016-05-02 2022-11-14 プロセナ バイオサイエンシーズ リミテッド タウ免疫療法
SG11201910066QA (en) 2017-05-02 2019-11-28 Prothena Biosciences Ltd Antibodies recognizing tau
EA202091012A1 (ru) 2017-10-25 2020-08-27 Янссен Фармасьютикалз, Инк. Композиции фосфорилированных тау-пептидов и их применения
EP3885362A4 (en) 2018-11-22 2022-08-17 Fujirebio Inc. ANTIBODY CONJUGATE
CN113710269A (zh) 2019-02-08 2021-11-26 Ac免疫有限公司 磷酸化Tau肽疫苗的安全施用方法
WO2020180819A1 (en) 2019-03-03 2020-09-10 Prothena Biosciences Limited Antibodies recognizing tau
EA202192891A1 (ru) 2019-04-24 2022-02-04 Янссен Фармасьютикалз, Инк. Гетерологичное введение анти-тау вакцин
JPWO2021065306A1 (da) * 2019-09-30 2021-04-08
EP4135841A1 (en) 2020-04-15 2023-02-22 Voyager Therapeutics, Inc. Tau binding compounds
CN111349617B (zh) * 2020-05-25 2020-09-22 苏州仁端生物医药科技有限公司 一种分泌抗Tau或pTau-181/231/396单克隆抗体杂交瘤细胞株及其应用
AU2021403010A1 (en) 2020-12-16 2023-07-13 Voyager Therapeutics, Inc. Tau binding compounds
WO2022144406A1 (en) 2020-12-29 2022-07-07 Neurimmune Ag Human anti-tau antibodies
CN113005096B (zh) * 2021-01-19 2022-10-14 华中科技大学 分泌抗丝氨酸磷酸化tau蛋白单克隆抗体的杂交瘤细胞株
WO2023250388A1 (en) 2022-06-22 2023-12-28 Voyager Therapeutics, Inc. Tau binding compounds
WO2024059739A1 (en) 2022-09-15 2024-03-21 Voyager Therapeutics, Inc. Tau binding compounds

Also Published As

Publication number Publication date
EP0673418B1 (en) 1998-05-06
WO1994013795A1 (en) 1994-06-23
ES2118373T3 (es) 1998-09-16
US5843779A (en) 1998-12-01
JP2879975B2 (ja) 1999-04-05
AU5809794A (en) 1994-07-04
EP0673418A1 (en) 1995-09-27
JPH08502898A (ja) 1996-04-02
DE69318420T2 (de) 1999-01-28
DE69318420D1 (de) 1998-06-10
ATE165866T1 (de) 1998-05-15
AU690092B2 (en) 1998-04-23

Similar Documents

Publication Publication Date Title
DK0673418T3 (da) Monoklonale antistoffer rettet mod mikrotubulusassocieret tau-protein, hybridomaer, der secernerer disse antistoffer, antig
DK0610330T3 (da) Monoklonale antistoffer mod microtubulus-associeret protein tau
Hamsten et al. Identification of galactose‐α‐1, 3‐galactose in the gastrointestinal tract of the tick I xodes ricinus; possible relationship with red meat allergy
ATE302411T1 (de) Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens
ATE208820T1 (de) Humanisierte antikoerper
ES2161751T3 (es) Anticuerpo monoclonal que se une especificamente al endotelio vascular tumoral y usos del mismo.
GR3025630T3 (en) Monoclonal antibody against human IgE
KR900701318A (ko) 항-사람 고분자량- 흑색종 관련 항원에 대한 항-이디오 타입 항체
Mageed et al. Restricted light chain subgroup expression on human rheumatoid factor paraproteins determined by monoclonal antibodies.
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
Cooper et al. Quantitation of surface-membrane and intracellular gamma, mu and kappa chains of normal and neoplastic human lymphocytes
ATE111606T1 (de) Ein gattungsspezifisches listeria-antigen, identifiziert durch monoklonale antikörper.
D'Amelio et al. Detection and partial characterization of circulating immune complexes in hydatid disease
Dziarski Anti-immunoglobulin autoantibodies are not preferentially induced in polyclonal activation of human and mouse lymphocytes, and more anti-DNA and anti-erythrocyte autoantibodies are induced in polyclonal activation of mouse than human lymphocytes.
CA2150816A1 (en) Monoclonal antibodies directed against the microtubule- associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and theirapplications
Evans et al. Investigation of the idiotypic determinants of IgM monoclonal proteins associated with neuropathy.
Grov et al. AN EXAMINATION OF THE “STAR‐PHENOMENON”, A THREE COMPONENT IMMUNOPRECIPITATION INVOLVING STAPHYLOCOCCAL PROTEIN A
Süsal et al. Role of anti-IgG autoantibodies in kidney transplantation
Lebon et al. HLA antigens in acute measles encephalitis
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
Terness et al. Role of idiotype-independent anti-IgG autoantibodies in human kidney transplantation: Natural anti-F (ab') 2 antibodies recognize an igG1 hinge region epitope
Waller et al. The hydrolysis of human IgG with subtilisin
Sluis et al. Inhibition of idiotype-anti-idiotype reaction in particle counting immunoassay as a tentative assay of IgE
Pfreundschuh et al. Monoclonal anti-idiotype antibodies against lymphoma-associated cold agglutinins
Etlinger et al. Netwhat?